Follow
Christopher Yeh Chen
Christopher Yeh Chen
In Vivo Lead, Dyno Therapeutics
Verified email at dynotx.com
Title
Cited by
Cited by
Year
Advances and future challenges in adenoviral vector pharmacology and targeting
R Khare, C Y Chen, E A Weaver, M A Barry
Current gene therapy 11 (4), 241-258, 2011
1992011
Cell patterning without chemical surface modification: Cell–cell interactions between printed bovine aortic endothelial cells (BAEC) on a homogeneous cell-adherent hydrogel
CY Chen, JA Barron, BR Ringeisen
Applied surface science 252 (24), 8641-8645, 2006
892006
Purification of Exosome-Like Vesicles from Urine
C Chen, M Hogan, C Ward
Methods in Enzymology 524, 225-241, 2013
582013
Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX
MP Marsh, SK Campos, ML Baker, CY Chen, W Chiu, MA Barry
Journal of virology 80 (23), 11881-11886, 2006
482006
Species D adenoviruses as oncolytics against B-cell cancers
CY Chen, JS Senac, EA Weaver, SM May, DF Jelinek, P Greipp, T Witzig, ...
Clinical Cancer Research 17 (21), 6712-6722, 2011
412011
Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapy
SE Hofherr, JS Senac, CY Chen, DJ Palmer, P Ng, MA Barry
Human gene therapy 20 (2), 169-180, 2009
392009
Targeting adenoviruses with factor X–single-chain antibody fusion proteins
CY Chen, SM May, MA Barry
Human gene therapy 21 (6), 739-749, 2010
282010
Mining the adenovirus virome for oncolytics against multiple solid tumor types
CY Chen, EA Weaver, R Khare, SM May, MA Barry
Cancer gene therapy 18 (10), 744-750, 2011
252011
Real-time dynamic imaging of virus distribution in vivo
SE Hofherr, KE Adams, CY Chen, S May, EA Weaver, MA Barry
PloS one 6 (2), e17076, 2011
252011
Single-component multilayered self-assembling protein nanoparticles presenting glycan-trimmed uncleaved prefusion optimized envelope trimers as HIV-1 vaccine candidates
YN Zhang, J Paynter, A Antanasijevic, JD Allen, M Eldad, YZ Lee, ...
Nature communications 14 (1), 1985, 2023
182023
Systemic delivery of therapeutic viruses.
MA Barry, SE Hofherr, CY Chen, JS Senac, ML Hillestad, EV Shashkova
Current Opinion in Molecular Therapeutics 11 (4), 411-420, 2009
182009
Mining the Adenovirus Virome for Systemic Oncolytics
MB Chen Chen, Eric Weaver
Current Pharmaceutical Biotechnology 13 (9), 1804-8, 2012
15*2012
Comparison of Adenoviruses as Oncolytics and Cancer Vaccines in an Immunocompetent B Cell Lymphoma Model
E Weaver, C Chen, S May, M Barry, M Barry
Human Gene Therapy 22 (9), 1095-1100, 2011
152011
Woolly monkey–HBV infection in squirrel monkeys as a surrogate nonhuman primate model of HBV infection
CY Chen, BY Winer, D Chavez, B Guerra, KM Brasky, S Eng, E Salas, ...
Hepatology communications 4 (3), 371-386, 2020
132020
Ex Vivo and In Vivo CD46 Receptor Utilization by Species D HumanAdenovirus Serotype 26 (HAdV26)
J Hemsath, M Liaci, J Rubin, B Parrett, SC Lu, T Nguyen, M Turner, ...
Journal of Virology, 2021
122021
Clinical Next-Generation Sequencing for Somatic Mutation Detection-Advancements and Commercialization Strategies
A Hesse, C Chen, H Reddi
Advances in Molecular Diagnostics 1 (1), 2015
22015
Enhanced Gene Delivery to the Kidney by Viral and Non-Viral Vectors
JD Rubin, TV Nguyen, KL Allen, CY Chen, MA Barry
MOLECULAR THERAPY 26 (5), 114-115, 2018
2018
SHORT-TERM RESCUE OF NEONATAL LETHALITY IN A MOUSE MODEL OF PROPIONIC ACIDEMIA BY UNMODIFIED AND PEGYLATED ADENOVIRAL VECTORS
SE Hofherr, JS Senac, CY Chen, DJ Palmer, P Ng, MA Barry
MOLECULAR GENETICS AND METABOLISM 98 (1-2), 122-122, 2009
2009
The system can't perform the operation now. Try again later.
Articles 1–18